Mizuho on Immatics (IMTX): 'BMS Cell Therapy Collaboration Discontinued, but No Material Impact; Stock Attractive Here'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Mizuho on Immatics (IMTX): 'BMS Cell Therapy Collaboration Discontinued, but No Material Impact; Stock Attractive Here'
(NASDAQ: IMTX) Delayed: 9.44 -0.15 (1.56%)
Previous Close $9.59    52 Week High $ 
Open $9.68    52 Week Low $ 
Day High $9.68    P/E N/A 
Day Low $9.39    EPS $ 
Volume 362,693